Registration Dossier

Toxicological information

Carcinogenicity

Currently viewing:

Administrative data

Description of key information

As the substance is not mutagenic and no hyperplasia or pre-neoplastic lesions were observed in any of the repeated dose tests performed with the analogues (even no treatment-related effects), carcinogenicity is not expected and does not need to be tested.

Key value for chemical safety assessment

Carcinogenicity: via oral route

Endpoint conclusion
Endpoint conclusion:
no study available

Carcinogenicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Carcinogenicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

Based on the above considerations, the substance does not need to be classified according to the Dangerous Substance Directive 67/548/EC and CLP Regulation (EC) 1272/2008.

Additional information

Value used for CSA: Carcinogenicity: negative